CARsgen lands $186m Series C

CARsgen, a biotechnology firm, has raised $186 million in Series C funding.

CARsgen, a biotechnology firm, has raised $186 million in Series C funding. The investors included Loyal Valley Capital, Lilly Asia Ventures, Shiyu Capital, Summer Capital and South China Venture Capital.

Source: Press Release